by The global cell and tissue preservation market is characterized by the growing need for regenerative medicine research activities and cell-based therapies. Cell and tissue preservation helps maintain the integrity and viability of cells and tissues outside the living organism by protecting them from deterioration. The increasing adoption of preserved biological samples in drug discovery, personalized medicine, and medical research is propelling the demand for cell and tissue preservation products. The growing applications of preserved samples in regenerative medicine studies and clinical research along with the technological developments in cryopreservation techniques are also fueling the market growth.
Global Cell And Tissue Preservation Market is estimated to be valued at USD 5.11 Bn in 2024 and is expected to reach USD 10.82 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031.
Key Takeaways
Key players operating in the global cell and tissue preservation market are Thermo Fisher Scientific, Inc., Lonza, BD, MerckKGaA, Cytiva, Agilent Technologies, Inc., Avantor, Inc., FUJIFILM Irvine Scientific, BioLifeSolutions Inc., AMSBIO, Princeton CryoTech, STEMCELL Technologies Inc., LGC SeraCare, Corning Incorporated, CellGenix GmbH.
Key opportunities in the market include growing regenerative medicine industry. The increasing R&D funding and favorable government policies supporting regenerative medicine research is expected to fuel the demand for preserved cell and tissue samples. Global Cell And Tissue Preservation Market Growth is crucial for developing regenerative therapies by deriving induced pluripotent stem cells from fibroblasts or other adult cell types to study diseases and develop new treatments.
Globally, North America dominates the cell and tissue preservation market owing to increasing research activities in regenerative medicine. Asia Pacific is expected to witness highest growth during the forecast period owing to growing biobanking sector and rising initiatives to support life sciences research in countries like China and India. Expanding biotechnology industry and growing investment in bioscience infrastructure development are driving the adoption of cell and tissue preservation products in emerging nations.
Market drivers
The increasing demand for biobanks for storing human samples is a major driver for cell and tissue preservation market growth. Biobanks play a pivotal role in personalized medicine research by facilitating access to preserved biological specimens. Growing applications of preserved samples in drug discovery, toxicity testing, and development of cell-based therapies provides immense opportunities for market players. Technological advancements in automated cryopreservation equipment and introduction of closed-system solutions ensure high viability and quality of stored samples, augmenting the market expansion.
PEST Analysis
Political: Stringent regulations and standards regarding the storage and handling of biological samples. Government support for cell and tissue preservation through funding and initiatives.
Economic: Increasing healthcare spending worldwide driving the growth. Rising incidence of chronic diseases leading to more cell and tissue samples collected for research.
Social: Growing public-private collaborations and partnerships aiding R&D. Increasing preference for regenerative medicine andStem cell therapy boostingdemand.
Technological: Advancements in cryopreservation techniques for long-term storage. Automation and digitization streamlining processes.
Geographical Regions with High Concentration
North America accounts for the largest share of the Global Cell and Tissue Preservation Market Regional Analysis in terms value, owing to presence of key players and advanced healthcare infrastructure. The region witnessed significant growth in stem cell banking and cord blood preservation. Asia Pacific is poised to be the fastest growing region supported by healthcare investments and expanding biobanks in major countries.
Fastest Growing Region
Asia Pacific region is witnessing the fastest growth in the global cell and tissue preservation market led by China, India and Japan. Stem cell therapy is gaining prominence fueling infrastructure developments. Initiatives to establish national cord blood banks along with increasing awareness regarding regenerative medicine offer lucrative opportunities. Favorable regulations and low manufacturing costs are attracting investments.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
